Leveraging Pharmacogenomics in Asthma for Predication, Mechanism and Endotyping
Leveraging Pharmacogenomics in Asthma for Predication, Mechanism and Endotyping
Recruiting · NCT06385236 · Registry updated 2024-08-19Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Leveraging Pharmacogenomics in Asthma for Predication, Mechanism and Endotyping | Hypersensitivity, Immediate, Respiratory Hypersensitivity, asthma, bronchial disorder, immune system disorder, lung disorder, obstructive lung disease, respiratory system disorder | Recruiting | Phase 4 | 2024-08-19 | NCT06385236 |
7 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Brigham and Women's Hospital | 378 |
| Harvard University | 37 |
| Mayo Clinic | 970 |
| National Heart, Lung, and Blood Institute (NHLBI) | 791 |
| University of Arizona | 138 |
| University of California, San Diego | 337 |
| Yale University | 458 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Mayo Clinic | Scottsdale | United States | 39 |
| University of California, San Diego | La Jolla | United States | 38 |
| Yale University | New Haven | United States | 352 |